Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting

Pyoderma gangrenosum (PG) is a relatively rare inflammatory skin disease that progressively causes necrotic ulceration mainly on the lower extremities and trunk. Systemic corticosteroid is considered a first-line treatment for PG as it facilitates wound healing; however, several cases where tumor ne...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hiroyuki Goto, Yoshimoto Okada, Seimi Watanabe, Kanako Danno, Shinya Yamamoto, Ryohei Ishiura, Yuichi Nakayama, Kohei Mitsui, Ayaka Ueki, Yasuo Nakai, Mitsunaga Narushima, Keiichi Yamanaka
Formato: article
Lenguaje:EN
Publicado: Karger Publishers 2021
Materias:
Acceso en línea:https://doaj.org/article/0a97645d2d9d4b7c88b2ec2055f13568
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0a97645d2d9d4b7c88b2ec2055f13568
record_format dspace
spelling oai:doaj.org-article:0a97645d2d9d4b7c88b2ec2055f135682021-11-18T11:08:46ZSuccessful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting1662-656710.1159/000519659https://doaj.org/article/0a97645d2d9d4b7c88b2ec2055f135682021-10-01T00:00:00Zhttps://www.karger.com/Article/FullText/519659https://doaj.org/toc/1662-6567Pyoderma gangrenosum (PG) is a relatively rare inflammatory skin disease that progressively causes necrotic ulceration mainly on the lower extremities and trunk. Systemic corticosteroid is considered a first-line treatment for PG as it facilitates wound healing; however, several cases where tumor necrosis factor-α inhibitors, adalimumab and infliximab, were administered showed good response. For intractable PG with a large ulcer or problematic epithelization, chemical or mechanical debridement of necrotic tissue in combination with skin grafting may be necessary to promote wound healing. Our report presents a case of intractable ulcerative PG requiring oral prednisolone and skin grafting. Although mechanical debridement was performed, granulation was poor; therefore, after the PG activity became quiescent, we utilized a vacuum-assisted closure (VAC) system to promote granulation and adaptation of the grafted skin. Although more cases are required for a definitive conclusion, the VAC system may be a choice for PG with large ulcers.Hiroyuki GotoYoshimoto OkadaSeimi WatanabeKanako DannoShinya YamamotoRyohei IshiuraYuichi NakayamaKohei MitsuiAyaka UekiYasuo NakaiMitsunaga NarushimaKeiichi YamanakaKarger Publishersarticlepyoderma gangrenosumcorticosteroidvacuum-assisted closureskin graftingDermatologyRL1-803ENCase Reports in Dermatology, Vol 13, Iss 3, Pp 497-501 (2021)
institution DOAJ
collection DOAJ
language EN
topic pyoderma gangrenosum
corticosteroid
vacuum-assisted closure
skin grafting
Dermatology
RL1-803
spellingShingle pyoderma gangrenosum
corticosteroid
vacuum-assisted closure
skin grafting
Dermatology
RL1-803
Hiroyuki Goto
Yoshimoto Okada
Seimi Watanabe
Kanako Danno
Shinya Yamamoto
Ryohei Ishiura
Yuichi Nakayama
Kohei Mitsui
Ayaka Ueki
Yasuo Nakai
Mitsunaga Narushima
Keiichi Yamanaka
Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
description Pyoderma gangrenosum (PG) is a relatively rare inflammatory skin disease that progressively causes necrotic ulceration mainly on the lower extremities and trunk. Systemic corticosteroid is considered a first-line treatment for PG as it facilitates wound healing; however, several cases where tumor necrosis factor-α inhibitors, adalimumab and infliximab, were administered showed good response. For intractable PG with a large ulcer or problematic epithelization, chemical or mechanical debridement of necrotic tissue in combination with skin grafting may be necessary to promote wound healing. Our report presents a case of intractable ulcerative PG requiring oral prednisolone and skin grafting. Although mechanical debridement was performed, granulation was poor; therefore, after the PG activity became quiescent, we utilized a vacuum-assisted closure (VAC) system to promote granulation and adaptation of the grafted skin. Although more cases are required for a definitive conclusion, the VAC system may be a choice for PG with large ulcers.
format article
author Hiroyuki Goto
Yoshimoto Okada
Seimi Watanabe
Kanako Danno
Shinya Yamamoto
Ryohei Ishiura
Yuichi Nakayama
Kohei Mitsui
Ayaka Ueki
Yasuo Nakai
Mitsunaga Narushima
Keiichi Yamanaka
author_facet Hiroyuki Goto
Yoshimoto Okada
Seimi Watanabe
Kanako Danno
Shinya Yamamoto
Ryohei Ishiura
Yuichi Nakayama
Kohei Mitsui
Ayaka Ueki
Yasuo Nakai
Mitsunaga Narushima
Keiichi Yamanaka
author_sort Hiroyuki Goto
title Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
title_short Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
title_full Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
title_fullStr Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
title_full_unstemmed Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
title_sort successful treatment of ulcerative-type pyoderma gangrenosum with a combination therapy of oral prednisolone, vacuum-assisted closure, and skin grafting
publisher Karger Publishers
publishDate 2021
url https://doaj.org/article/0a97645d2d9d4b7c88b2ec2055f13568
work_keys_str_mv AT hiroyukigoto successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT yoshimotookada successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT seimiwatanabe successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT kanakodanno successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT shinyayamamoto successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT ryoheiishiura successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT yuichinakayama successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT koheimitsui successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT ayakaueki successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT yasuonakai successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT mitsunaganarushima successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT keiichiyamanaka successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
_version_ 1718420826219347968